BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9972875)

  • 1. Expression of the GM1-species, [NeuN]-GM1, in a case of human glioma.
    Fredman P; Månsson JE; Dellheden B; Boström K; von Holst H
    Neurochem Res; 1999 Feb; 24(2):275-9. PubMed ID: 9972875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel gangliosides containing lactosaminyl-GM1 structure from rat spleen.
    Nohara K; Suzuki M; Inagaki F; Ito H; Kaya K
    J Biol Chem; 1990 Aug; 265(24):14335-9. PubMed ID: 2387854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural studies of gangliosides from the YAC-1 mouse lymphoma cell line by immunological detection and fast atom bombardment mass spectrometry.
    Müthing J; Peter-Katalinić J; Hanisch FG; Neumann U
    Glycoconj J; 1991 Oct; 8(5):414-23. PubMed ID: 1841683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cell surface neoganglioproteins. GM1-neoganglioproteins are non-functional receptors for cholera toxin.
    Pacuszka T; Fishman PH
    J Biol Chem; 1990 May; 265(13):7673-8. PubMed ID: 2159009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent derivatives of ganglioside GM1 function as receptors for cholera toxin.
    Spiegel S
    Biochemistry; 1985 Oct; 24(21):5947-52. PubMed ID: 3002428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside composition in human meningiomas.
    Davidsson P; Fredman P; Collins VP; von Holst H; Mänsson JE; Svennerholm L
    J Neurochem; 1989 Sep; 53(3):705-9. PubMed ID: 2760617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipolytic action of cholera toxin on fat cells. Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor.
    Kanfer JN; Carter TP; Katzen HM
    J Biol Chem; 1976 Dec; 251(23):7610-9. PubMed ID: 1002701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain.
    von Holst H; Nygren C; Boström K; Collins VP; Fredman P
    Acta Neurochir (Wien); 1997; 139(2):141-5. PubMed ID: 9088372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel ganglioside with a free amino group in bovine brain.
    Hidari KI; Irie F; Suzuki M; Kon K; Ando S; Hirabayashi Y
    Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):259-63. PubMed ID: 8250852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of the carboxyl group of sialic acid in binding of cholera toxin to the receptor glycosphingolipid, GM1.
    Lanne B; Schierbeck B; Karlsson KA
    J Biochem; 1994 Dec; 116(6):1269-74. PubMed ID: 7706216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 3-dependent mouse mast cells express the cholera toxin-binding acidic glycosphingolipid, ganglioside GM1, and increase their histamine content in response to toxin.
    Katz HR; Levine JS; Austen KF
    J Immunol; 1987 Sep; 139(5):1640-6. PubMed ID: 2957431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of various lysogangliosides including lyso-fucosyl GM1 and delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometric analysis.
    Taketomi T; Hara A; Uemura K; Kurahashi H; Sugiyama E
    J Biochem; 1997 Feb; 121(2):264-9. PubMed ID: 9089399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental changes of gangliosides of the rat stomach. Appearance of a blood group B-active ganglioside.
    Bouhours JF; Bouhours D; Hansson GC
    J Biol Chem; 1987 Dec; 262(34):16370-5. PubMed ID: 3680254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain gangliosides of quaking and shiverer mutants: qualitative and quantitative changes of monosialogangliosides in the quaking brain.
    Iwamori M; Harpin ML; Lachapelle F; Baumann N
    J Neurochem; 1985 Jul; 45(1):73-8. PubMed ID: 3998734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the cholera toxin receptor on Balb/c 3T3 cells as a ganglioside similar to, or identical with, ganglioside GM1. No evidence for galactoproteins with receptor activity.
    Critchley DR; Streuli CH; Kellie S; Ansell S; Patel B
    Biochem J; 1982 Apr; 204(1):209-19. PubMed ID: 7052064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin.
    Masserini M; Freire E; Palestini P; Calappi E; Tettamanti G
    Biochemistry; 1992 Mar; 31(8):2422-6. PubMed ID: 1311601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoganglioside alpha-fucosyl(alpha-galactosyl)-GM1: a novel member of lipid membrane microdomain components involved in PC12 cell neuritogenesis.
    Yamazaki Y; Horibata Y; Nagatsuka Y; Hirabayashi Y; Hashikawa T
    Biochem J; 2007 Oct; 407(1):31-40. PubMed ID: 17608628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and metabolism of exogenous gangliosides by cultured cells: effect of choleragen on the turnover of GM1.
    Fishman PH; Bradley RM; Hom BE; Moss J
    J Lipid Res; 1983 Aug; 24(8):1002-11. PubMed ID: 6631229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of monosialosyl pentahexaosylceramide GalNAc-GM1 as specific tumor-associated ganglioside of human head and neck squamous cell carcinomas.
    Bolot G; David MJ; Kasama T; Taki T; Handa S; Richard M; Pignat JC; Thomas L; Portoukalian J
    Cancer Lett; 1999 Jan; 135(2):159-64. PubMed ID: 10096424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.